After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Zai Lab Limited ADR is $3.33B. A total of 1.53 million shares were traded on the day, compared to an average of 1.14M shares.
In the most recent transaction, Smiley Joshua L sold 3,354 shares of ZLAB for 33.11 per share on Apr 04 ’25. After the transaction, the insider now owns 67,345 company shares. In a previous transaction on Apr 04 ’25, Edmondson Frazor Titus III sold 1,874 shares at 33.11 per share. ZLAB shares that Chief Legal Officer owns now total 30,375.
Among the insiders who sold shares, Du Ying disposed of 2,945 shares on Apr 04 ’25 at a per-share price of $33.11. This resulted in the Chairperson & CEO holding 479,851 shares of ZLAB after the transaction. In another insider transaction, Chen Yajing sold 924 shares at $33.11 per share on Apr 04 ’25. Company shares held by the Chief Financial Officer now total 27,047.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ZLAB has a high of $39.77 and a low of $13.48.
As of this writing, ZLAB has an earnings estimate of -$0.54 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.47 per share and a lower estimate of -$0.69.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ZLAB’s latest balance sheet shows that the firm has $1.41B in Cash & Short Term Investments as of fiscal 2021. There were $15.54M in debt and $192.90M in liabilities at the time. Its Book Value Per Share was $7.80, while its Total Shareholder’s Equity was $1.38B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZLAB is Buy with a score of 4.75.
